Home
Finance
Companies
Industry
Market

NASDAQ:GLUE

Monte Rosa Therapeutics Inc [GLUE] stock Downgrade by Wells Fargo analyst, price target now $11

September 16, 2025

Caleb Clifford

Monte Rosa Therapeutics Inc [NASDAQ: GLUE] traded at a high on 2025-09-15, posting a 44.07 gain after which it closed ...

most recent

Finance

why Bruker Corp [BRKR] is a Good Choice for Investors After New Price Target of $44.92

Companies

T1 Energy Inc [TE] Stock trading around $3.83 per share: What’s Next?

Market

Fate Therapeutics Inc [FATE] fell -47.21% so far this year. What now?

Industry

Market cap of Celsius Holdings Inc [CELH] reaches 16.58B – now what?

Finance

Wall Street Analyst Resumed Akero Therapeutics Inc [AKRO]. What else is Wall St. saying

Companies

Chardan Capital Markets slashes price target on Novonix Limited ADR [NVX] – find out why.

Who We Are

At DBT News, we cover what matters locally — with in-depth reporting, contributor perspectives, visual storytelling, and community feedback. Our goal is to keep you informed and engaged through open, respectful dialogue that rises above partisanship.

Quick Links

About Us
Contact Us
Disclaimer
Our Team
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled